These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 37435448)
21. β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids. Gatto F; Feelders RA; van der Pas R; van Koetsveld P; Bruzzone E; Arvigo M; Dogan F; Lamberts S; Ferone D; Hofland L J Endocrinol; 2020 Apr; 245(1):101-113. PubMed ID: 32027601 [TBL] [Abstract][Full Text] [Related]
22. Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation. Kageyama K; Asari Y; Sugimoto Y; Niioka K; Daimon M Endocr J; 2020 Feb; 67(2):177-184. PubMed ID: 31666445 [TBL] [Abstract][Full Text] [Related]
23. Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation. Peverelli E; Giardino E; Vitali E; Treppiedi D; Lania AG; Mantovani G Horm Metab Res; 2014 Nov; 46(12):845-53. PubMed ID: 25068602 [TBL] [Abstract][Full Text] [Related]
24. Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists. van der Pas R; Feelders RA; Gatto F; de Bruin C; Pereira AM; van Koetsveld PM; Sprij-Mooij DM; Waaijers AM; Dogan F; Schulz S; Kros JM; Lamberts SW; Hofland LJ J Clin Endocrinol Metab; 2013 Dec; 98(12):E1880-90. PubMed ID: 24081741 [TBL] [Abstract][Full Text] [Related]
25. Genetics of Cushing's disease: from the lab to clinical practice. Theodoropoulou M; Reincke M Pituitary; 2022 Oct; 25(5):689-692. PubMed ID: 35852754 [TBL] [Abstract][Full Text] [Related]
31. A Novel Mechanism Regulating Dopamine Receptor Type 2 Signal Transduction in Pituitary Tumoral Cells: The Role of cAMP/PKA-Induced Filamin A Phosphorylation. Mangili F; Treppiedi D; Catalano R; Marra G; Di Muro G; Spada A; Arosio M; Peverelli E; Mantovani G Front Endocrinol (Lausanne); 2020; 11():611752. PubMed ID: 33664708 [TBL] [Abstract][Full Text] [Related]
32. Somatostatin Receptor as a Molecular Imaging Target in Human and Canine Cushing Disease. De Ravin E; Phan HAT; Harmsen S; Cho SS; Teng CW; Petersson EJ; White C; Galban EM; Hess R; Lee JYK World Neurosurg; 2021 May; 149():94-102. PubMed ID: 33601082 [TBL] [Abstract][Full Text] [Related]
33. Decoding the genetic basis of Cushing's disease: USP8 in the spotlight. Theodoropoulou M; Reincke M; Fassnacht M; Komada M Eur J Endocrinol; 2015 Oct; 173(4):M73-83. PubMed ID: 26012588 [TBL] [Abstract][Full Text] [Related]
34. Advances in Molecular Pathophysiology and Targeted Therapy for Cushing's Disease. Takayasu S; Kageyama K; Daimon M Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672445 [TBL] [Abstract][Full Text] [Related]
35. Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas. Saveanu A; Gunz G; Dufour H; Caron P; Fina F; Ouafik L; Culler MD; Moreau JP; Enjalbert A; Jaquet P J Clin Endocrinol Metab; 2001 Jan; 86(1):140-5. PubMed ID: 11231991 [TBL] [Abstract][Full Text] [Related]
36. The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas. Regazzo D; Mondin A; Scaroni C; Occhi G; Barbot M Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742910 [TBL] [Abstract][Full Text] [Related]
37. The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas. Batista DL; Zhang X; Gejman R; Ansell PJ; Zhou Y; Johnson SA; Swearingen B; Hedley-Whyte ET; Stratakis CA; Klibanski A J Clin Endocrinol Metab; 2006 Nov; 91(11):4482-8. PubMed ID: 16940446 [TBL] [Abstract][Full Text] [Related]
38. Mutations in the deubiquitinase gene USP8 cause Cushing's disease. Reincke M; Sbiera S; Hayakawa A; Theodoropoulou M; Osswald A; Beuschlein F; Meitinger T; Mizuno-Yamasaki E; Kawaguchi K; Saeki Y; Tanaka K; Wieland T; Graf E; Saeger W; Ronchi CL; Allolio B; Buchfelder M; Strom TM; Fassnacht M; Komada M Nat Genet; 2015 Jan; 47(1):31-8. PubMed ID: 25485838 [TBL] [Abstract][Full Text] [Related]
39. Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells. Gatto F; Arvigo M; Amarù J; Campana C; Cocchiara F; Graziani G; Bruzzone E; Giusti M; Boschetti M; Ferone D Pituitary; 2019 Feb; 22(1):89-99. PubMed ID: 30483918 [TBL] [Abstract][Full Text] [Related]
40. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease. Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]